期刊论文

中文

中西医结合肝病杂志

1005-0264

2018

28

2

70-74

10.3969/j.issn.1005-0264.2018.02.002

国家“十一五”传染病重大专项课题资助项目（No.2008ZX10005-007）；

本校为第一机构

目的:探讨中西医结合治疗方案治疗乙型肝炎病毒（HBV）相关慢加急性肝衰竭和慢性肝衰竭患者的疗效。方法:采用前瞻性、多中心、随机对照研究方法,HBV相关慢加急性肝衰竭和慢性肝衰竭患者,分别按2:1的比例进入治疗组和对照组,观察第8周、第12周、第24周、第48周病死率。结果:HBV相关慢加急性肝衰竭患者在第8周、12周、24周、48周,两组病死率间差异有统计学意义（P0.05）。结论:中西医结合治疗方案可降低乙肝病毒相关慢加急性肝衰竭患者病死率,尤其对晚期患者在缺乏肝移植等手段时,西医常规治疗联合中药治疗可改善患者生存率。

Objective： To study the curative efficacy of Chinese and Western medicine treatment the virus hepatitis B virus associated acute-on-chronic liver failure and chronic hepatic failure. Methods： The perspective multicenter randomized control clinical trial was used.The patients who were liver failure and chronic hepatic failure had the ratio of 2： 1 access to treatment group and control group. Study the fatality rate between two groups in 8 weeks,12 weeks,24 weeks,and 48 weeks. Results： Patients＇ fatality rates about the hepatitis B virus ass...